Metropolis Healthcare Limited informed that Mr. Milind Sarwate (DIN: 00109854) has completed his term of 5 (five) years as an Independent Director of the Company on September 06, 2023. Consequently, he ceased to be a Director of the Company and Chairman/Member of Audit Committee, Risk Management Committee and Corporate Social Responsibility Committee with effect from the closure of business hours on September 06, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,831 INR | +4.76% | +0.95% | +9.11% |
May. 10 | India's Dr. LalPath Labs posts higher Q4 profit rises on healthy testing demand | RE |
Apr. 11 | Metropolis Healthcare Books 10% Increase in Fiscal Q4 Overall Revenue | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.11% | 1.07B | |
-15.12% | 8.49B | |
+60.25% | 4.08B | |
-43.01% | 2.42B | |
-9.98% | 2.42B | |
-3.24% | 2.33B | |
-3.40% | 2.01B | |
-19.79% | 1.53B | |
-40.57% | 1.26B | |
+13.28% | 985M |
- Stock Market
- Equities
- METROPOLIS Stock
- News Metropolis Healthcare Limited
- Metropolis Healthcare Limited Announces the Cessation of Milind Sarwate as an Independent Director, Chairman/Member of Audit Committee, Risk Management Committee and Corporate Social Responsibility Committee, Effective September 06, 2023